🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

MindRank AI clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with MindRank AI as lead sponsor. Synced 26 Sep 2026
5Current trials
0Recruiting now
3Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

MindRank AI is the lead sponsor of 5 current clinical trials in our China register. None of its ClinicalTrials.gov trials is recruiting at the moment. The most common phase is Phase 1. The drugs named most often in its trials are MDR-001, Itraconazole and Rifampin. The most-studied condition is Overweight or Obesity.

ClinicalTrials.gov trials by status

  • Not yet open5100%

Trials by phase

  • Phase 1360%
  • Phase 3120%
  • Phase 2120%
01

Clinical trials sponsored by MindRank AI

5 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE)
NCT07274137 · ClinicalTrials.gov ↗ · Overweight or Obesity
Drug: MDR-001
Phase 3 Not yet open 2026-02 China
Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight
NCT07110766 · ClinicalTrials.gov ↗ · Obesity &Amp; Overweight
Phase 1 Not yet open 2025-08 China
Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants
NCT07550621 · ClinicalTrials.gov ↗ · Healthy Volunteers (HV)
Phase 1 Not yet open 2026-05 China
Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment
NCT07550634 · ClinicalTrials.gov ↗ · Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B), Hepatic Insufficiency (MeSH ID: D048550)
Drug: MDR-001
Phase 1 Not yet open 2026-06 China
A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight
NCT06606483 · ClinicalTrials.gov ↗ · Obesity, Overweight and Obesity
Drug: MDR-001
Phase 2 Not yet open 2024-09 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in MindRank AI trials

3 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in MindRank AI trials

7 conditions
Overweight or Obesity1Obesity &Amp; Overweight1Healthy Volunteers (HV)1Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B)1Hepatic Insufficiency (MeSH ID: D048550)1Obesity1Overweight and Obesity1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China50

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Overweight or Obesity

SponsorTrials
CSPC Ouyi Pharmaceutical3
Clinical Nutrition Research Center, Illinois Institute of Technology2
BrightGene Bio-Medical Technology2
Fujian Shengdi Pharmaceutical2
Innovent Biologics Technology Limited (Shanghai R&D Center)1
Suzhou Alphamab1

Sponsors with the most current trials registered for this condition.

06

Questions about MindRank AI trials

How many clinical trials does MindRank AI sponsor?

MindRank AI is the lead sponsor of 5 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are MindRank AI trials recruiting?

Not at the moment. None of its 5 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.

Which drugs is MindRank AI testing?

Its current trials name 3 drugs and biologicals as interventions. The most frequent are MDR-001 (4), Itraconazole (1) and Rifampin (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.